Cardiovascular-kidney-metabolic health age using wearables and blood biomarkers

Cardiovascular-Kidney-Metabolic (CKM) syndrome represents a growing public health crisis, yet its subclinical heterogeneity remains underexplored. Early detection of physiological deviation is critical for preventing irreversible organ damage. Here, we characterize the prevalence and interplay of CKM impairment in a US cohort (WEAR-ME study, N = 819 participants) by integrating continuous wearable data with clinical biomarkers. We assessed cardiovascular, kidney via clinical biomarkers, namely Chol/HDL, eGFR, as well as metabolic health risk through Homeostatic Model Assessment of Insulin Resistance (HOMA-IR). We show that while metabolic and cardiovascular disruptions are significantly associated ( r = 0.26, p < 0.001), early-stage kidney impairment manifests independently. Utilizing a normalized deviance score, we identified significant health impairments in 29.0% of the cohort. Cardiovascular deviation was the most prevalent singular phenotype (13.3%), followed by metabolic (9.1%) and renal (6.25%) deviations, with dual metabolic-cardiovascular impairment occurring in only 2.2% of participants. These findings suggest that high system-specific deviance may serve as an indicator for accelerated physiological aging within the respective organ system. Furthermore, step count, active zone minutes, and resting heart rate were identified as the key wearable predictors of cardiovascular and metabolic decline. Leveraging wearables metrics and blood biomarkers, we developed a CKM Health Age model that tracks physiological health, aligning with established clinical standards (Metabolic syndrome severity and modified AHA Life’s Essential 8) and user-reported overall health. These findings underscore the necessity of a multi-system subtyping approach, demonstrating that wearable-derived phenotypes and routine blood biomarkers can facilitate the early, targeted interventions required to manage the complex landscape of CKM syndrome.

Authors

Institutions

Publication Details

Journal
npj Digital Medicine
Published
2026-11-17
DOI
https://doi.org/10.1038/s41746-026-03433-4
Citations
1
Primary Topic
Diabetes, Cardiovascular Risks, and Lipoproteins
Type
article
Field-Weighted Citation Impact
2.73
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cardiovascular-kidney-metabolic health age using wearables and blood biomarkers

Zeinab Esmaeilpour, Menglian Zhou, Cathy Speed, A. Ali Heydari et al.
1 citations
npj Digital Medicine
Diabetes, Cardiovascular Risks, and Lipoproteins
2.73
article

Cardiovascular-kidney-metabolic health age using wearables and blood biomarkers

Zeinab Esmaeilpour, Menglian Zhou, Cathy Speed, A. Ali Heydari, Lindsey Sunden, Conor Heneghan, Cathy A. Speed, Javier L. Prieto, Ahmed A. Metwally, Anthony Z. Faranesh, Daniel McDuff, Mark Malhotra, Zechen Li
article en
1 citations

Abstract

Cardiovascular-Kidney-Metabolic (CKM) syndrome represents a growing public health crisis, yet its subclinical heterogeneity remains underexplored. Early detection of physiological deviation is critical for preventing irreversible organ damage. Here, we characterize the prevalence and interplay of CKM impairment in a US cohort (WEAR-ME study, N = 819 participants) by integrating continuous wearable data with clinical biomarkers. We assessed cardiovascular, kidney via clinical biomarkers, namely Chol/HDL, eGFR, as well as metabolic health risk through Homeostatic Model Assessment of Insulin Resistance (HOMA-IR). We show that while metabolic and cardiovascular disruptions are significantly associated ( r = 0.26, p < 0.001), early-stage kidney impairment manifests independently. Utilizing a normalized deviance score, we identified significant health impairments in 29.0% of the cohort. Cardiovascular deviation was the most prevalent singular phenotype (13.3%), followed by metabolic (9.1%) and renal (6.25%) deviations, with dual metabolic-cardiovascular impairment occurring in only 2.2% of participants. These findings suggest that high system-specific deviance may serve as an indicator for accelerated physiological aging within the respective organ system. Furthermore, step count, active zone minutes, and resting heart rate were identified as the key wearable predictors of cardiovascular and metabolic decline. Leveraging wearables metrics and blood biomarkers, we developed a CKM Health Age model that tracks physiological health, aligning with established clinical standards (Metabolic syndrome severity and modified AHA Life’s Essential 8) and user-reported overall health. These findings underscore the necessity of a multi-system subtyping approach, demonstrating that wearable-derived phenotypes and routine blood biomarkers can facilitate the early, targeted interventions required to manage the complex landscape of CKM syndrome.

npj Digital Medicine
Google (United States) (US)
Good health and well-being
Openalex Percentile: Top 15%
Diabetes, Cardiovascular Risks, and Lipoproteins
2.73
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon